Merck, the renowned US pharmaceuticals giant known as MSD across Europe, has abandoned plans for a £1 billion research centre in London—a significant blow for the UK life sciences sector.
All posts tagged in nhs drug pricing
2Articles
The UK government’s recently unveiled life sciences sector plan has faced sharp criticism from industry leaders for failing to address key concerns about investment in innovative medicines. The 78-page strategy,
